Podcast

Governor Larry Hogan 'Still Standing' After Cancer

Author(s):

Jessica Skarzynski

In this week’s episode of the CURE Talks Cancer podcast, Maryland Governor Larry Hogan opens up about what it was like to go through cancer not once but twice, and why he considers every day a gift.

In 2015, Maryland Governor Larry Hogan had only been in office for five months when he was diagnosed with an advanced, aggressive form of non-Hodgkin’s lymphoma. Then, after achieving remission, he was diagnosed with a common form of skin cancer in 2018.

But thanks to an attentive health care team, and the help of his friends, family and fellow patients, today he’s cancer-free and sharing his story.

In this week’s episode of the CURE® Talks Cancer podcast, Governor Hogan spoke with us about what it was like to go through cancer not once but twice, and why he considers every day a gift.

Related Videos
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Treatment with cemacabtagene ansegedleucel demonstrated responses in patients with relapsed or treatment-resistant large B-cell lymphoma.
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of a woman with a brown hair tied into a bun.
Related Content
Image of cells.
March 5th 2025

Brukinsa Combo Shows Efficacy and Safety For Double-Expressor Lymphoma

Spencer Feldman
Brukinsa plus R-CHOP demonstrated high efficacy and durable responses in double-expressor lymphoma, with manageable safety, supporting further phase 3 trials.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Cema-cel demonstrated durable responses in patients with relapsed/refractory large B-cell lymphoma; © Nattapat - stock.adobe.com
February 28th 2025

Cema-Cel Has Durable Responses in in Relapsed/Refractory Large B-Cell Lymphoma

Ryan Scott
Treatment with the CAR T-cell therapy cema-cel demonstrated durable responses in patients with relapsed/refractory large B-cell lymphoma.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Illustration of blood cells.
February 24th 2025

Odronextamab is Safe and Effective in R/R DLBCL After Progression on CAR T

Ryan Scott
Odronextamab demonstrated a manageable safety profile and generated durable responses in patients with R/R DLBCL who have progressed after CAR-T therapy.
Image of water bottle, weights, and apple.
February 22nd 2025

Debunking the Myth That Healthy People Don’t Get Cancer

Jacey Tramutt Amy Schneidmiller-Johnston
The myth that "healthy people don’t get cancer" contributed to my shame, but I’ve learned that cancer can affect anyone, regardless of lifestyle choices.